التفاصيل البيبلوغرافية
العنوان: |
High-dose oral vitamin D supplementation for prevention of infections in children aged 0 to 59 months: a systematic review and meta-analysis. |
المؤلفون: |
Carboo, Janet Adede, Dolman-Macleod, Robin Claire, Malan, Linda, Lombard, Martani Johanni |
المصدر: |
Nutrition Reviews; May2024, Vol. 82 Issue 5, p579-599, 21p |
مصطلحات موضوعية: |
INFLUENZA prevention, THERAPEUTIC use of vitamin D, PHARMACEUTICAL arithmetic, COLD (Temperature), PNEUMONIA, ANTIBIOTICS, RESPIRATORY infections, DRUG side effects, CINAHL database, PRIMARY health care, HOSPITAL care, ORAL drug administration, META-analysis, DESCRIPTIVE statistics, FEVER, IMMUNE system, HOSPITAL mortality, SYSTEMATIC reviews, MEDLINE, ODDS ratio, DRUG efficacy, MATHEMATICAL models, ONLINE information services, TREATMENT effect heterogeneity, COMPARATIVE studies, CONFIDENCE intervals, THEORY, COUGH, DATA analysis software, VITAMIN D, DIETARY supplements, EVALUATION, CHILDREN |
مستخلص: |
Context Vitamin D plays an important role in immune function, and the deficiency thereof has been associated with several infections, most notably respiratory tract infections. However, data from intervention studies investigating the effect of high-dose vitamin D supplementation on infections have been inconclusive. Objective The aim of this study was to evaluate the level of evidence regarding the efficacy of vitamin D supplementation above the standard dose (400 IU) in preventing infections in apparently healthy children < 5 years of age. Data Sources PubMed, Scopus, Science Direct, Web of Science, Google Scholar, CINAHL, and MEDLINE electronic databases were searched between August 2022 and November 2022. Seven studies met the inclusion criteria. Data Extraction Meta-analyses of outcomes in more than one study were performed using Review Manager software. Heterogeneity was evaluated using the I2 statistic. Randomized controlled trials in which vitamin D was supplemented at > 400 IU compared with placebo, no treatment, or standard dose were included. Data Analysis Seven trials that enrolled a total of 5748 children were included. Odds ratios (ORs) with 95%CIs were calculated using random- and fixed-effects models. There was no significant effect of high-dose vitamin D supplementation on the incidence of upper respiratory tract infection (OR, 0.83; 95%CI, 0.62–1.10). There was a 57% (95%CI, 0.30–0.61), 56% (95%CI, 0.27–0.07), and 59% (95%CI, 0.26–0.65) reduction in the odds of influenza/cold, cough, and fever incidence, respectively, with daily supplementation of vitamin D > 1000 IU. No effect was found on bronchitis, otitis media, diarrhea/gastroenteritis, primary care visits for infections, hospitalizations, or mortality. Conclusion High-dose vitamin D supplementation provided no benefit in preventing upper respiratory tract infections (moderate certainty of evidence) but reduced the incidence influenza/cold (moderate certainty of evidence), cough, and fever (low certainty of evidence). These findings are based on a limited number of trials and should be interpreted with caution. Further research is needed. Systematic Review Registration PROSPERO registration number CRD42022355206. [ABSTRACT FROM AUTHOR] |
|
Copyright of Nutrition Reviews is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |